{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:24:06Z","timestamp":1792185846223,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005224","name":"National Center for Immunization and Respiratory Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30121P11283"],"award-info":[{"award-number":["75D30121P11283"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126312","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T19:53:54Z","timestamp":1725998034000},"page":"126312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study"],"prefix":"10.1016","volume":"42","author":[{"given":"Winston E.","family":"Abara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharareh","family":"Modaressi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Fireman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Layefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Kirkcaldy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousseny","family":"Zerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126312_bb0005","author":"U.S. Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2024.126312_bb0010","author":"U.S. Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2024.126312_bb0015","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.15585\/mmwr.mm6950a6","article-title":"Update to CDC\u2019s treatment guidelines for gonococcal infection, 2020","volume":"69","author":"Cyr","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.126312_bb0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.126312_bb0025","doi-asserted-by":"crossref","first-page":"2200455","DOI":"10.2807\/1560-7917.ES.2022.27.24.2200455","article-title":"Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022","volume":"27","author":"Pleininger","year":"2022","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2024.126312_bb0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/OLQ.0000000000001332","article-title":"Planning for a gonococcal vaccine: a narrative review of vaccine development and public health implications","volume":"48","author":"Abara","year":"2021","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1473-3099(22)00002-0","article-title":"Is the end of gonorrhea in sight?","volume":"22","author":"Ong","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recommendations Reports"},{"key":"10.1016\/j.vaccine.2024.126312_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01668-19","article-title":"Group A-RNgW, Wang X. Genetic similarity of gonococcal homologs to meningococcal outer membrane proteins of serogroup B vaccine","volume":"10","author":"Marjuki","year":"2019","journal-title":"Mbio"},{"key":"10.1016\/j.vaccine.2024.126312_bb0050","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1473-3099(21)00812-4","article-title":"Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhea: a retrospective observational study","volume":"22","author":"Abara","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0055","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1093\/cid\/ciac436","article-title":"Prevention of Neisseria gonorrhoeae with meningococcal B vaccine: a matched cohort study in Southern California","volume":"76","author":"Bruxvoort","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0060","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1473-3099(21)00754-4","article-title":"Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhea in an infant, child, and adolescent programme: an observational cohort and case-control study","volume":"22","author":"Wang","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2023.05.021","article-title":"4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhea at three years post programme implementation","volume":"87","author":"Wang","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2024.126312_bb0070","first-page":"247","article-title":"Meningococcus B vaccination effectiveness against Neisseria gonorrhoeae infection in people living with HIV: a case-control study","volume":"50","author":"Raccagni","year":"2023","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.31742","article-title":"Association of group B meningococcal vaccine receipt with reduced gonorrhea incidence among university students","volume":"6","author":"Robison","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2024.126312_bb0080","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2024.126312_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00236-6","article-title":"Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomized trial with a 2\u00a0\u00d7\u00a02 factorial design","author":"Molina","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0090","first-page":"20","article-title":"The Kaiser Permanente northern California adult member health survey","author":"Gordon","year":"2016","journal-title":"Perm J"},{"key":"10.1016\/j.vaccine.2024.126312_bb0095","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202110190","article-title":"Chlamydia and gonorrhea","volume":"174","author":"Dombrowski","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2024.126312_bb0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.2021.10577","article-title":"Screening for chlamydial and gonococcal infections: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"Cantor","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2024.126312_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Vaccination of infants with meningococcal group B vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.126312_bb0110","author":"U.S. Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2024.126312_bb0115","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/OLQ.0b013e31820ff9a4","article-title":"The natural history of incident gonococcal infection in adolescent women","volume":"38","author":"Stupiansky","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0120","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/infdis\/jiac408","article-title":"Neisseria gonorrhoeae infection in women increases with rising gonococcal burdens in partners: chlamydia coinfection in women increases gonococcal burden","volume":"226","author":"Su","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0125","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41564-018-0182-y","article-title":"Chlamydia trachomatis paralyses neutrophils to evade the host innate immune response","volume":"3","author":"Rajeeve","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2024.126312_bb0130","series-title":"Screening recommendations and considerations referenced in treatment guidelines and original sources","article-title":"Sexually transmitted infections treatments guidelines","author":"U.S. Centers for Disease Control and Prevention","year":"2021"},{"key":"10.1016\/j.vaccine.2024.126312_bb0135","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/OLQ.0000000000000294","article-title":"Interventions to improve sexually transmitted disease screening in clinic-based settings","volume":"43","author":"Taylor","year":"2016","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2024.126312_bb0140","author":"National Library of Medicine"},{"key":"10.1016\/j.vaccine.2024.126312_bb0145","author":"National Library of Medicine"},{"key":"10.1016\/j.vaccine.2024.126312_bb0150","author":"National Library of Medicine"},{"key":"10.1016\/j.vaccine.2024.126312_bb0155","author":"National Library of Medicine"},{"key":"10.1016\/j.vaccine.2024.126312_bb0160","author":"National Library of Medicine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:41:35Z","timestamp":1741887695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24009940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24009940"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126312","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of a serogroup B meningococcal vaccine against gonorrhea: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126312"}}